The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1β and IL-6 production through a caspase 1-dependent mechanism
Open accessAbstract
The activation of innate immunity requires the amplification of signals induced by pattern-recognition receptors for bacterial products. We have investigated the role of the newly described cytokine IL-32 in the amplification of cytokine production induced by the two most clinically relevant families of microbial receptors, the cell-surface Toll-like receptors (TLRs) and the intracellular nuclear oligomerization domain (NOD) receptor family. IL-32 synergized with the NOD1- and NOD2-specific muropeptides of peptidoglycans for the release of IL-1β and IL-6 (a 3- to 10-fold increase). In contrast, IL-32 did not influence the cytokine production induced via TLRs. The synergistic effect of IL-32 and synthetic muramyl dipeptide (MDP) on cytokine production was absent in the cells of patients with Crohn's disease bearing the NOD2 frameshift mutation 3020insC, demonstrating that the IL-32/MDP synergism depends on NOD2. This in vitro synergism between IL-32 and NOD2 ligands was consistent with a marked constitutive expression of IL-32 in human colon epithelial tissue. In addition, the potentiating effect of IL-32 on the cytokine production induced by the synthetic muropeptide FK-156 was absent in NOD1-deficient macrophages, supporting the interaction between IL-32 and NOD1 pathways. When specific caspase inhibitors were used, the synergism between IL-32 and MDP/NOD2 depended on the activation of caspase 1. Only additive effects of IL-32 and muropeptides were observed for TNF-α production. The modulation of intracellular NOD2 pathways by IL-32, but not cell-surface TLRs, and the marked expression of IL-32 in colon mucosa suggest a role of IL-32 in the pathogenesis of Crohn's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., & Sansonetti, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200651200 · Cited by 2,408
Self-citationNod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nuñez, G., & Flavell, R. A. (2005) · Science · doi:10.1126/science.1104911 · Cited by 1,776
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
Girardin, S. E., Boneca, I. G., Carneiro, L. A. M., Antignac, A., Jéhanno, M., Viala, J., Tedin, K., Taha, M.-K., Labigne, A., Zäthringer, U., et al. (2003) · Science · doi:10.1126/science.1084677 · Cited by 1,577
Self-citationInferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,466
Dendritic-cell control of pathogen-driven T-cell polarization
Kapsenberg, M. L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1246 · Cited by 1,437
Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., et al. (2003) · Nature Immunology · doi:10.1038/ni945 · Cited by 1,323
Martinon, F., & Tschopp, J. (2004) · Cell · doi:10.1016/j.cell.2004.05.004 · Cited by 938
RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems
Kobayashi, K., Inohara, N., Hernandez, L. D., Galán, J. E., Núñez, G., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Nature · doi:10.1038/416194a · Cited by 893
Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
Maeda, S., Hsu, L.-C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., & Karin, M. (2005) · Science · doi:10.1126/science.1103685 · Cited by 749
CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells
Hisamatsu, T., Suzuki, M., Reinecker, H.-C., Nadeau, W. J., McCormick, B. A., & Podolsky, D. K. (2003) · Gastroenterology · doi:10.1053/gast.2003.50153 · Cited by 634
MIF regulates innate immune responses through modulation of Toll-like receptor 4
Roger, T., David, J., Glauser, M. P., & Calandra, T. (2001) · Nature · doi:10.1038/414920a · Cited by 584
Identification of Bacterial Muramyl Dipeptide as Activator of the NALP3/Cryopyrin Inflammasome
Martinon, F., Agostini, L., Meylan, E., & Tschopp, J. (2004) · Current Biology · doi:10.1016/j.cub.2004.10.027 · Cited by 579
Puren, A. J., Fantuzzi, G., Gu, Y., Su, M. S., & Dinarello, C. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1379 · Cited by 545
Self-citationKim, S.-H., Han, S.-Y., Azam, T., Yoon, D.-Y., & Dinarello, C. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.003 · Cited by 535
Self-citationBlocking IL-1 in systemic inflammation
Dinarello, C. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050640 · Cited by 494
Self-citationFaure, E., Thomas, L., Xu, H., Medvedev, A. E., Equils, O., & Arditi, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2018 · Cited by 451
Wolfs, T. G. A. M., Buurman, W. A., van Schadewijk, A., de Vries, B., Daemen, M. A. R. C., Hiemstra, P. S., & van ’t Veer, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1286 · Cited by 442
Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study
Hampe, J., Grebe, J., Nikolaus, S., Solberg, C., Croucher, P. J., Mascheretti, S., Jahnsen, J., Moum, B., Klump, B., Krawczak, M., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08590-2 · Cited by 409
Abreu, M. T., Arnold, E. T., Thomas, L. S., Gonsky, R., Zhou, Y., Hu, B., & Arditi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110333200 · Cited by 356
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease
van Heel, D. A., Ghosh, S., Butler, M., Hunt, K. A., Lundberg, A. M., Ahmad, T., McGovern, D. P., Onnie, C., Negoro, K., Goldthorpe, S., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66582-8 · Cited by 312
Bosisio, D., Polentarutti, N., Sironi, M., Bernasconi, S., Miyake, K., Webb, G. R., Martin, M. U., Mantovani, A., & Muzio, M. (2002) · Blood · doi:10.1182/blood.v99.9.3427 · Cited by 290
Netea, M. G., Ferwerda, G., de Jong, D. J., Jansen, T., Jacobs, L., Kramer, M., Naber, T. H. J., Drenth, J. P. H., Girardin, S. E., Jan Kullberg, B., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6518 · Cited by 273
Self-citationRole of Nod2 in the Response of Macrophages to Toll-Like Receptor Agonists
Pauleau, A.-L., & Murray, P. J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.21.7531-7539.2003 · Cited by 260
Nods: a family of cytosolic proteins that regulate the host response to pathogens
Inohara, N. (2002) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(02)00289-8 · Cited by 243
NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease
Netea, M. G., Kullberg, B. J., de Jong, D. J., Franke, B., Sprong, T., Naber, T. H. J., Drenth, J. P. H., & Van der Meer, J. W. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425229 · Cited by 216
Self-citationNACHT-LRR proteins (NLRs) in bacterial infection and immunity
Kufer, T. A., Fritz, J. H., & Philpott, D. J. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.06.004 · Cited by 151
Yoo, N. J., Park, W. S., Kim, S. Y., Reed, J. C., Son, S. G., Lee, J. Y., & Lee, S. H. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02714-6 · Cited by 100
Self-citation
Cited by
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity
Creagh, E. M., & O’Neill, L. A. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.003 · Cited by 762
Tumour immunity: effector response to tumour and role of the microenvironment
Mantovani, A., Romero, P., Palucka, A. K., & Marincola, F. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60241-x · Cited by 537
Immunologic messenger molecules: Cytokines, interferons, and chemokines
Commins, S. P., Borish, L., & Steinke, J. W. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.008 · Cited by 479
Metadata
- Authors
- Netea, M. G., Azam, T., Ferwerda, G., Girardin, S. E., Walsh, M., Park, J.-S., Abraham, E., Kim, J.-M., Yoon, D.-Y., Dinarello, C. A., & Kim, S.-H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-10-31
- Volume
- 102
- Issue
- 45
- Pages
- 16309-16314
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1973394808
- Cited by
- 289
- References
- 31
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.